Nifty pared 59 points, or 0.55 per cent, finishing day's trade at 10,762.

Consumer stocks stole the show with Nifty FMCG surging 2.36 per cent to close at 26,459.55.

Equity benchmarks were trading flat as gains in IT and telecom stocks were offset by losses in bank and metal stocks.

The stock plunged 10.71 per cent to settle at Rs 140 on the BSE. In intra-day, it declined by 11.28 per cent to Rs 139.10.

Panacea Biotec Ltd slipped as much as 9.89 per cent in trade on Friday, after the company a standalone net loss of Rs 36.90 crore.

Drug firm Panacea Biotec today reported a standalone net loss of Rs 36.90 crore for the quarter ended June 30, 2015.

Panacea Biotec today posted a net profit of Rs 82.79 crore for the third quarter ended December 31, 2013.

Panacea Biotec today reported a net loss of Rs 56.27 crore for the second quarter ended September 30.

Drug firm Panacea Biotec today reported a net loss of Rs 82.75 crore for the fourth quarter ended March 31, 2013.

Pharma firm Panacea Biotec today reported net loss of 62.28 crore for the third quarter ended December 31, 2012.

Panacea Biotec and Bestech will hold an equal stake in the project, which is expected to generate revenues of over Rs 1,500 crore.

ET Now spoke to various experts and here's what they have to recommend for today's trade.

Panacea Biotec Ltd is a ‘buy’ call with a stop loss of Rs 113.5.

Panacea Biotec today posted a net loss of Rs 65.97 crore for the first quarter ended June 30, 2012.

The company had posted a net profit of Rs 42.60 crore for the quarter ended December 31, 2010, Panacea Biotec said in a filing to BSE.

Panacea Biotec today posted a net profit of Rs 57.52 crore for the fourth quarter ended March 31, 2010.

Sandeep Wagle, Founder & MD, APTART Technical Advisory Services, in a chat with ET Now talks about his stock picks.